RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 4 ML (560 MG)
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1236100980030 -
GGREM
525226070029207 -
Código de barras
5413787224425
O que a fonte publica
- Detentor do registro
- UCB BIOPHARMA LTDA.
- Princípios ativos
- ROZANOLIXIZUMABE
- Embalagem
- 140 MG / ML SOL INJ CT FR VD INC X 4 ML (560 MG)
- Tipo de produto
- Biológico
- Classe terapêutica
- M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 4 ML (560 MG)",
"holder": "UCB BIOPHARMA LTDA.",
"stripe": null,
"barcodes": [
"5413787224425"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525226070029207",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "64.711.500/0001-14",
"priceRegime": "Regulado",
"productName": "RYSTIGGO",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "140 MG / ML SOL INJ CT FR VD INC X 4 ML (560 MG)",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "52715.87",
"icms-12": "59904.42",
"icms-17": "63513.08",
"icms-18": "64287.64",
"icms-19": "65081.33",
"icms-20": "65894.84",
"icms-21": "66728.96",
"icms-22": "67584.43",
"icms-23": "68462.15",
"icms-17.5": "63898.01",
"icms-19.5": "65485.55",
"icms-20.5": "66309.29",
"icms-22.5": "68020.50",
"icms-12-alc": "53486.10",
"icms-17-alc": "56708.10",
"icms-18-alc": "57399.68",
"icms-19-alc": "58108.28",
"icms-20-alc": "58834.65",
"icms-21-alc": "59579.42",
"icms-22-alc": "60343.22",
"icms-23-alc": "61126.90",
"withoutTaxes": "47067.73",
"icms-17.5-alc": "57051.80",
"icms-19.5-alc": "58469.23",
"icms-20.5-alc": "59204.67",
"icms-22.5-alc": "60732.53"
},
"pisCofinsList": "Negativa",
"substanceText": "ROZANOLIXIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "70716.46",
"icms-12": "80359.65",
"icms-17": "85200.54",
"icms-18": "86239.58",
"icms-19": "87304.29",
"icms-20": "88395.58",
"icms-21": "89514.52",
"icms-22": "90662.11",
"icms-23": "91839.54",
"icms-17.5": "85716.91",
"icms-19.5": "87846.53",
"icms-20.5": "88951.55",
"icms-22.5": "91247.08",
"icms-12-alc": "73941.40",
"icms-17-alc": "78395.62",
"icms-18-alc": "79351.69",
"icms-19-alc": "80331.29",
"icms-20-alc": "81335.45",
"icms-21-alc": "82365.05",
"icms-22-alc": "83420.96",
"icms-23-alc": "84504.35",
"withoutTaxes": "65068.38",
"icms-17.5-alc": "78870.77",
"icms-19.5-alc": "80830.28",
"icms-20.5-alc": "81846.98",
"icms-22.5-alc": "83959.16"
},
"invalidBarcodes": [],
"activeSubstances": [
"ROZANOLIXIZUMABE"
],
"therapeuticClass": "M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": "(AR)",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1236100980030",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "M5X",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525226070029207"